Predicting amyloid PET positivity using plasma p‐tau181 and other blood‐based biomarkers

Abstract Introduction This study aimed to determine the efficacy of combining plasma phosphorylated tau (p‐tau)181, amyloid beta (Aβ)42/Aβ40, neurofilament light (NfL), and apolipoprotein E (APOE) genotypes for detecting positive amyloid positron emission tomography (PET), which is little known in t...

Cijeli opis

Bibliografski detalji

Glavni autori:	Hyuk Sung Kwon, Eun‐Hye Lee, Hyung‐Ji Kim, So‐Hee Park, Hyun‐Hee Park, Jee Hyang Jeong, Seong‐Ho Koh, Seong Hye Choi, Jae‐Hong Lee
Format:	Artigo
Jezik:	Inglês
Izdano:	Wiley 2023-10-01
Serija:	Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Teme:	Alzheimer's disease amyloid beta amyloid positron emission tomography APOE neurofilament light p‐tau181
Online pristup:	https://doi.org/10.1002/dad2.12502
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!